The emergence of a new variant of the seasonal influenza A(H3N2) virus has reignited debate around what the media has labeled the «super flu». This comes amid an unusually early rise in flu-like illnesses in several countries, including Morocco. In this interview, Dr. Tayeb Hamdi, physician and researcher in health policy and systems, addresses key questions about the nature of this variant, its risks, vaccine effectiveness, and recommended preventive measures.